Trial · NCT02921256
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Arm 1a v. Arm II | STARTED | Arm I (mFOLFOX6, RT, Capecitabine) | 88 | |
| Arm 1a v. Arm II | STARTED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 90 | |
| Arm 1a v. Arm II | STARTED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 0 | |
| Arm 1a v. Arm II | COMPLETED | Arm I (mFOLFOX6, RT, Capecitabine) | 72 | |
| Arm 1a v. Arm II | COMPLETED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 57 | |
| Arm 1a v. Arm II | COMPLETED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 0 | |
| Arm 1a v. Arm II | NOT COMPLETED | Arm I (mFOLFOX6, RT, Capecitabine) | 16 | |
| Arm 1a v. Arm II | NOT COMPLETED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 33 | |
| Arm 1a v. Arm II | NOT COMPLETED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 0 | |
| Arm Ib v Arm III | STARTED | Arm I (mFOLFOX6, RT, Capecitabine) | 95 | |
| Arm Ib v Arm III | STARTED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 0 | |
| Arm Ib v Arm III | STARTED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 90 | |
| Arm Ib v Arm III | COMPLETED | Arm I (mFOLFOX6, RT, Capecitabine) | 71 | |
| Arm Ib v Arm III | COMPLETED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 0 | |
| Arm Ib v Arm III | COMPLETED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 75 | |
| Arm Ib v Arm III | NOT COMPLETED | Arm I (mFOLFOX6, RT, Capecitabine) | 24 | |
| Arm Ib v Arm III | NOT COMPLETED | Arm II (mFOLFOX6, RT, Capecitabine, Veliparib) | 0 | |
| Arm Ib v Arm III | NOT COMPLETED | Arm III (mFOLFOX6, RT, Capecitabine, Pembrolizumab) | 15 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02921256/flow